StockRunway.com continuously monitors and scans the markets for day trading and swing trading signals on NASDAQ, NYSE, AMEX, OTCBB and Pink Sheet companies for its free e-newsletter subscribers.
New York, NY -- (SBWIRE) -- 03/04/2013 -- StockRunway.com issues special report on trending stocks of this morning – Groupon (NASDAQ:GRPN), MGIC Investment Corp. (NYSE:MTG) and Keryx Biopharmaceuticals (NASDAQ:KERX).
As Groupon (NASDAQ:GRPN) has detached itself of its quirky maker and CEO, the major question is whether the firm’s online deals business is capable enough to return its declining stock price, falling sales growth and fading consumer interest.
On Thursday, Groupon Inc. (GRPN) ousted Andrew Mason, one day following the firm another unsatisfactory quarter among doubts that people are tiring of the restaurant, spa and Botox deals that Groupon created its business on.
In a report to staff members, Groupon CEO Andrew Mason confessed he was unsuccessful at this part of the journey and reported the firm’s workers deserve the outside world to give you another chance. A new CEO earns you that chance.
What experts have to say about Groupon chief ousting? Find in this report
Mason’s ousting has been “fairly extensively predicted, given the firm’s performance, and the shock was how long it took, Gartner expert Michael Gartenberg reported. But a latest CEO might not be sufficient to tackle Groupon’s issues.
How on Thursday gained investors’ attention on Monday? Find out here
MGIC Investment Corp. (NYSE:MTG) reported after the trading session that its shares of MGIC Investment Corp. climbed up US$0.81 (or 27.18%) to US$3.79 with 33.83 million shares changing hands, in contrast to its average daily volume of 7.21 million shares.
Can Keryx Biopharmaceuticals Inc. stock end the day with robust change? Find out here
Keryx Biopharmaceuticals(NASDAQ:KERX) was changing hands in bearish zone on Monday trading session as Adam Feurstein of TheStreet.com reported on Twitter that the source of a speculation that GlaxoSmithKline (GSK) might be interested in Keryx Biopharmaceuticals (KERX) is the blog "Sierra World Equity Review.
StockRunway.com is an Elite Financial Stock website catering to individual investors, fund managers, investment bankers and equity analysts. Whether you're new to penny stocks or a seasoned veteran, you'll find all the information you will need right here! Our research is a remarkable educational tool for everyone to utilize.
Sign up TODAY and join the vast amount of investors already benefiting from the best free alerts from StockRunway's service today!
This report/release/advertisement is a commercial advertisement and is for general information purposes only. Never invest in any stock featured on our site, Press Releases or emails unless you can afford to lose your entire investment. The disclaimer is to be read and fully understood before using our site, or joining our email list. PLEASE NOTE WELL: StockRunway.com and its employees are not a Registered Investment Advisor, Broker Dealer or a member of any association for other research providers in any jurisdiction whatsoever. Read our Full Disclaimer by visiting our website.
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-321-1250 (International)